CORRECTED: FDA approves Merck vaccine to prevent shingles

In BOSTON story headlined “FDA approves Merck vaccine to
prevent shingles,” please read in second paragraph … The
vaccine is designed to prevent shingles … instead of … The
vaccine is designed to treat shingles.

A corrected version follows.

BOSTON (Reuters) – Merck & Co. said on Friday that the U.S.
Food and Drug Administration has approved its vaccine to
prevent shingles, a painful disease characterized by a
blistering rash.

The vaccine, Zostavax, is designed to prevent shingles in
individuals over the age of 60. Shingles is caused by the
reactivation of the virus that causes chickenpox.